
    ASTRAZENECA PHARMACEUTICALS LP and AstraZeneca UK Limited, Plaintiffs-Appellants, v. ANCHEN PHARMACEUTICALS, INC., Defendant and Osmotica Pharmaceutical Corporation, Defendant-Appellant, and Torrent Pharmaceuticals Limited and Torrent Pharma Inc., Defendants-Appellants, and Mylan Pharmaceuticals Inc. and Mylan Inc., Defendants-Appellants.
    Nos. 2012-1359, 2012-1360, 2012-1361, 2012-1362, 2012-1363, 2012-1364.
    United States Court of Appeals, Federal Circuit.
    Feb. 14, 2013.
    Henry J. Renk, Fitzpatrick, Celia, Harper & Scinto, of New York, NY, argued for plaintiffs-appellees. With him on the brief were Bruce C. Haas, Steven C. Kline, Michael P. McGraw, Dennis Gregory and Robert J. Czarnecki, Jr.
    Christopher T. Griffith, Leydig, Voit & Mayer, Ltd., of Chicago, IL, argued for defendant-appellant, Osmótica Pharmaceutical Corporation and William A. Rakoczy, Rakoczy Molino Mazzochi Siwik LLP, of Chicago, IL, argued for Defendants-appellants, Mylan Pharmaceuticals, Inc., et al. With them on the brief were Robert F. Green, Leydig, Voit & Mayer, Ltd. of Chicago, IL, Jamacia P. Szeliga, of Washington, DC, and Amy D. Brody, Rakoczy Mol-ino Mazzochi Siwik LLP, of Chicago, IL.
    H. Keeto Sabharwal, Sterne, Kessler, Goldstein & Fox, PLLC, of Washington, DC, argued for defendants-appellants, Torrent Pharmaceuticals Limited, et al. With him on the brief were Byron L. Pickard, Jonathan M. Strang and Dennies Varughese.
    MOORE, MAYER, and WALLACH, Circuit Judges.
   JUDGMENT

PER CURIAM.

This Cause having been heard and considered, it is

Ordered and Adjudged:

AFFIRMED. See Fed. Cir. R. 36.  